Eisai-Biogen to advance Alzheimer's drug , provide fresh hope
EghtesadOnline: Eisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer’s disease drug, BAN2401, and are working with regulators to design the next studies and gain expedited review as a breakthrough therapy.
|
Publish Date:24/July/2018 | 10:30